期刊文献+

放线菌生物活性物质的高通量筛选 被引量:6

High throuphput screening of bioactive substances from actinomycetes
原文传递
导出
摘要 放线菌是产生生物活性物质最多的一类微生物.最近3年,我室从云南省采集土样,分离到3000多株放线菌、真菌,选择其中2600株,进行发酵,制备成提取物,利用自建的抗氧化、抑制乙酰胆碱酶、抑制一氧化氮合成酶、AGE等模型和高通量筛选系统进行了筛选,筛选到一些值得进一步研究的菌株.对高通量筛选的有关问题及初步筛选结果进行了讨论. Actinomycetes are one of important microbial resources producing bioactive metabolites.2?600 actinomycete strains were isolated from soil samples collected from Yunnan.Each strain was fermented and extracted,and 2?600 extracts were obtained.These extracts were selected by using 4 models in vitro with High Through Screening system.Results of screening indicate that 0.4% strains have anti-oxidation,and 2.7%,(0.34%) and 0.3% of strains have inhibitions against AchE,NOS,and AGE respectively.Inhibition of strain YIM 32766 against AchE was 108.3%.Inhibition of one of elements of extracts of strain YIM 30243 against NOS was 151.8%.Inhibition of strain YIM32012,YIM32215,YIM32234,YIM32212,YIM32044 and YIM32025 against AGE were 300.66%,42.16%,133.94%,122.59%,110% and 101.71% respectively.These strains with high bioactivity should have potential value for future development of drug.
出处 《云南大学学报(自然科学版)》 CAS CSCD 2004年第4期364-366,共3页 Journal of Yunnan University(Natural Sciences Edition)
基金 科技部基础研究重大项目前期研究专项(2001CCC00600).
关键词 放线菌 生物活性物质 高通量筛选 药物开发 发酵 乙酰胆碱脂酶 Actinomycetes bioactive substances high throughput screening
  • 相关文献

参考文献5

二级参考文献23

  • 1[1]Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept[J]. Cardiovasc Res, 1998, 37(3):586-600.
  • 2[5]Wang J, Walsh K. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation[J]. Science, 1996, 273 (5273): 359-61.
  • 3[6]Wells-knecht K J, Brinkmann E. New biomarkers of Maillard reaction damage to protein[J]. Nephrol Dial Transplant, 1996, 1 l(Suppl 5):41-7.
  • 4[7]Min C, Kang E, Yu SH, et al. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells[J]. Diabetes Res Clin Pract, 1999,46(3): 197-202.
  • 5[8]Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end products-induced apoptosis of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured messangial cells[J]. J Biol Chem, 2002, 277(23): 20309-15.
  • 6[9]Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in hunan acute myocardial infarction[ J ]. Circulation, 1997, 95(2): 320-3.
  • 7[10]Olivetti C, Abbi R, Quaini F, et al. Apoptosis in the failing hman heart[J]. N Engl J Med, 1997, 336(16): 1131-41.
  • 8[11]Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes[J]. Cir Res, 1994, 75(3): 426-33.
  • 9[12]Turner NA, Xia F, Azhar G, et al. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells[J]. J Mol Cell Cardiol,1998, 30(9): 1789-801.
  • 10[13]Sabbah HN, Sharov VG. Apoptosis in heart failure [ J ]. Prog Cardiolvasc Dis, 1998, 40(6): 549-62.

共引文献70

同被引文献73

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部